iBio (IBIO) Long-Term Debt Issuances (2020 - 2025)
iBio (IBIO) posted quarterly Long-Term Debt Issuances of $17000.0 for Q4 2025, down 60.47% year-over-year from $43000.0 in Q4 2024, and down 63.83% quarter-over-quarter from $47000.0 in Q3 2025.
iBio (IBIO) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends
iBio (IBIO) has reported Long-Term Debt Issuances for 5 consecutive years, with $17000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Long-Term Debt Issuances fell 60.47% year-over-year to $17000.0; the TTM figure through Mar 2026 stood at $122000.0 (down 6.15% YoY), while the FY2025 annual figure was $218000.0, up 147.73% from the prior year.
- Long-Term Debt Issuances slipped to $17000.0 in Q4 2025 per IBIO's latest filing, from $47000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $6.2 million in Q4 2022 and bottomed at -$6.2 million in Q1 2023.
- Historically, Long-Term Debt Issuances has averaged $72500.0 across 4 years, with a median of $45000.0 in 2024.
- Annual changes were most pronounced in 2024 — Long-Term Debt Issuances plunged 106.0% — and 2025, when it surged 293.33%.
- iBio's Long-Term Debt Issuances stood at $6.2 million in 2022, then plunged by 98.75% to $78000.0 in 2023, then sank by 44.87% to $43000.0 in 2024, then plunged by 60.47% to $17000.0 in 2025.
- Business Quant data shows IBIO's Long-Term Debt Issuances at $17000.0 in Q4 2025, $47000.0 in Q3 2025, and $58000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 78,000.00 |
| Dec 31, 2023 | 78,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 500,000.00 |